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  Home Office 
  Foreword 
The availability of new psychoactive substances (NPS) has posed a new and significant challenge over 
the last few years. The Government is determined to clamp down on the trade in NPS, or so called “legal 
highs”, as they are unhelpfully known. The scale of use of different NPS can change very quickly but our 
knowledge and understanding of this is improving, as is our understanding of the wide range of harms 
these drugs can cause. NPS can be assumed neither to be safe or legal. A number of NPS have caused 
paranoia, psychosis, seizures and deaths. Many have been untested or had only limited testing on humans, 
so not all the risks from taking them, alone or in combination with other substances, are yet known. We do 
know that many NPS can cause a very similar range of problems to the drugs which they mimic, including 
a risk of dependence developing with repeated use. Some appear to be more dangerous even than the 
traditional drugs they mimic. In addition all these risks are likely to be exacerbated by their use with other 
substances and alcohol. 
Our recently published response to the expert panel on NPS sets out proactive work to tackle these new drugs 
over the last few years. We have already banned more than 500 NPS. We have led successive communications 
campaigns, ensuring consistent and evidence-based messaging on the risks of NPS, provided guidance to 
schools and, via FRANK, have provided information on the risks of taking “legal highs” amongst young people. 
We have also created a world-leading Forensic Early Warning System to identify NPS in the UK, supported law 
enforcement agencies on a concerted programme of action, led the international effort to tackle the availability of 
these new drugs and are developing new treatment guidelines for NPS. 
We recognise that there is more to do to tackle NPS and our ambition to have a real impact on this 
emerging threat remains high. As informal educators and frontline practitioners you may find yourself 
supporting individuals who may take illicit drugs and / or NPS, or who may approach you for advice about 
them. Your work here is vital as you may be the first, or only, point of direct contact for those seeking this 
information, support and advice. 
We recognise that there is no easy answer to this matter. The fact is that the situations you come across 
may vary greatly, making addressing NPS challenging. However you said you would like to have more 
information on the origins and descriptions of NPS and you wanted to hear from your peers on the 
approaches and tools they use in their work. 
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Therefore, a group of experienced practitioners from Mentor UK, DrugScope, local youth 
and drug treatment services and a Youth Offending Team have developed this resource 
pack, offering a range of informed approaches to assist you in tackling the issue of NPS. 
This pack has been specifically developed for those in roles such as key workers and 
practitioners in specialist and targeted services such as youth services, drug treatment 
services or youth offending teams. 
As practitioners who work with young people, you will already have the necessary 
skills to help those using NPS to change their behaviours. This pack aims to 
communicate what we currently know about the use and effect of NPS, however much 
of the information and advice provided can be equally applicable to all drug taking 
behaviour.  
Equally any interaction with users about NPS should form part of a broader discussion 
about drug use in general.
A common goal in working with young people at risk from the choices they may make, is to build their 
emotional resilience and to provide them with the skills and confidence they need to reject pressures they 
face. 
We hope this pack will support you in this important role by providing useful information, case studies and 
practical tools to help you challenge any drug taking behaviour of those you may come into contact with. 
Produced, thanks to contributions from:
 •  Rick Bradley, Service Manager, KCA Young People’s Service 
 •  Simon Claridge, Director of Programmes, Mentor Adepis
 •  Michael Lawrence, NPS & On-Line Technologies Development Manager, CRI
 •  Harry Shapiro, Director of Communications and Information, DrugScope
 •  Becka Jarvis, Senior Youth Worker and Youth Team Manager, Community First HEH
 •   Georgia Ramsay-Smith, New Psychoactive Substance & Club Drug Outreach Worker, Brighton & 
Hove
 •  Pete Xeros, Jade Gora and Justin Laidler, Youth Offending Team for North Tyneside
 •  Public Health England
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  Introduction 
Children and young people growing up in the 21st Century are exposed to risk. Risk and risk-taking are a 
natural part of the transition into adulthood. But what do we mean by risk? In young people’s lives there are:
 •   risk factors: those circumstances whereby the best outcomes are compromised due to, among 
other things, poverty, deprivation, ill health and poor relationships.
 •   risk behaviours: potentially harmful behaviours such as smoking, alcohol and substance misuse 
and unsafe sex. 
 •   young people at risk:  this term is used to refer to those who are potentially vulnerable, such as 
subject to abuse or neglect or in care or custody. 
New Psychoactive Substances (NPS) or so called “legal highs” present a danger because:
 •  they are easily accessible 
 •  are constantly being adapted to avoid legislative control 
 •  they may not necessarily hold the same perceived threat to health and well-being as illegal drugs
 •   some young people are unaware that just because they are advertised as legal, doesn’t mean they 
are safe or legal - by definition, this exposes young people to risk and participation in risky 
behaviours
It is important therefore that we are clear about how we respond to risk and the part it plays in the 
lives of (vulnerable) young people. Equally important is that, where possible, interventions are made 
using evidence-based practice. Young people have told us, for example, that they welcome personal 
development that enables them to navigate risk, to build their self-efficacy and life skills and to feel able to 
resist peer pressure without threatening friendships and meaningful relationships. 
Some of the young people I work with  
know a lot about NPS – I need to 
make sure I know my stuff too.
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   All you need to know  
about NPS in 5 minutes
“Help! What are NPS?”
NPS are drugs that are designed to replicate the effects of illegal substances.  People may refer to these 
drugs as “legal highs”, but many of the substances are now under the control of the Misuse of Drugs 
Act 1971. Some NPS products can also contain illegal substances even if advertised as a “legal high”.  
Therefore NPS is a more accurate term because the main intention of the manufacturers is to produce 
psychoactive substances that allow them – and users – to evade the law.
“They’re quite new aren’t they?” 
NPS began to appear in the UK drug scene around 2008/09. Mephedrone is probably the most well known 
example.
“Where do they come from, who makes them and where are they sold?” 
NPS are generally manufactured in China and, to a far lesser extent, India. The bulk importation of NPS is 
often done via mail and fast parcel services. The Home Office evidence review on NPS in England 2014 
found that NPS are then distributed to users through friends, dealers and headshops with only a minority of 
users buying directly from the web. The DrugScope Street Drug Trends Survey 2013 also found evidence 
that other retail outlets including garages, newsagents and takeaways were selling substances to their 
customers. New materials appear rapidly on the market and if popular can quickly dominate the NPS 
market, as was the case with mephedrone.
“There seem to be so many; I just don’t know how to keep up.” 
Media attention is often given to announcements that significant numbers of ‘new drugs’ have been 
identified. A common misconception is that these new drugs are all as different from each other as ecstasy 
is from heroin. However, it is highly likely that any new drug identified will fit into one of the five categories 
described below. Whilst some substances may have a combination of effects (e.g. MDMA/Ecstasy is a 
psychedelic and a stimulant; and cannabis/synthetic cannabinoids are downers and psychedelics), there is 
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virtually no NPS that you cannot easily fit into one of the following five groups.  
This can be important because, once understood, it helps with being more confident about what some of 
the effects and risks of a particular NPS might be:
•   Stimulant-type drugs: these drugs have a significant simulant/alerting effect on the brain and 
mimic substances such as amphetamine, cocaine and ecstasy and include BZP, mephedrone, 
MPDV, NRG-1, Benzo Fury, MDAI, ethylphenidate.
•   ‘Downers’/tranquiliser-type/sedative-type drugs (aka ‘depressants’) drugs: these drugs 
have a significant inhibitory and relaxing effect on the brain and mimic various sedating, 
anti-anxiety and opioid-like drugs (and alcohol). Including, for example, new drugs from 
the benzodiazepine family (such as etizolam, pyrazolam and flubromazepam, Nitrous Oxide and 
new synthetic opioids).
•   Hallucinogenic drugs: these drugs make users hallucinate, feel relaxed and happy or on a bad 
trip agitated and confused. These drugs mimic substances like LSD and include 25i-NBOMe, 
Bromo-Dragonfly and methoxetamine which is similar to ketamine.
•   Dissociative drugs: a category of drugs which mimic substances such as PCP (Phencyclidine), 
ketamine, DXM, whose main effect is causing a feeling of being detached, as if the mind and 
body have been separated, with some people feeling incapable of moving. They can also cause 
hallucinations and have both stimulant and depressant effects. 
•   Synthetic cannabinoids: these are synthetic drugs that are designed to mimic the action of 
the active chemical found in cannabis and are traded under such names as: Spice, Clockwork 
Orange, Black Mamba and Exodus Damnation. They are not derived from the cannabis plant. 
These could be included as downer-type drugs with psychedelic effects but given their current 
wide range and potency, they are described here as a separate group.
 
“How prevalent are NPS and who uses them?”  
While the number of different NPS detected is 
increasing across Europe, it is important to keep 
things in perspective. We should not dismiss the 
positive picture seen as a result of the current 
approach of targeted, consistent and evidence-
based messaging on the risks of drugs (including 
NPS), raised awareness of the risks of “legal 
highs” and rapidly developing clinical responses 
via frontline services. Alongside this, there has been a long term downward trend in drug use in England 
and Wales and among 11 to 15 year olds, drug use has continued to fall since a peak in 2003.
An example of the shifting patterns of use is seen with Mephedrone, which has been illegal since 2010, with 
use among 16‐ to 24‐year‐olds falling at least once in the last year from a peak of 4.4% in 2010/11 to 1.9% 
in 2013/141. Mephedrone is the most prevalent of the NPS measured in the Crime Survey for England and 
Wales although it does not measure all NPS.
 Further information on substances can be 
found on the national drugs information 
service www.talktofrank.com  
Some practitioners have told us that they 
also find the drugswheel helpful.
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However, some reports do suggest that NPS is more prevalent in rural areas and within some subgroups, 
for example, clubbers and men who have sex with men. Although small in comparison to the number 
of those referred to treatment services for use of illegal drugs there are however anecdotal reports from 
experts and specialist organisations, such as DrugScope, that the use of NPS among groups of vulnerable 
young people, particularly in communities with high poverty rates, widespread unemployment and social 
deprivation is increasingly becoming a cause for concern. Some of the most frequently cited reasons for 
using NPS include: their relative availability, price, purity and consistency, and the capacity to purchase 
online. 
Understanding of national prevalence of NPS use is patchy, which is why it is important that local 
commissioners and providers develop an understanding of prevalence and the broader social context 
of NPS use among their local populations. This information will be key for you in determining how you 
respond in your local area. Public Health England has recently released a tool-kit for substance misuse 
commissioners that guides them in monitoring and sharing both local and national information. Speak to 
your local PHE centre team if you are interested in discussing the toolkit in more depth, contact details can 
be found at PHE’s website.
In response to the increased media exposure on NPS, including already banned substances such as 
mephedrone, it is vital to remember that, as with illegal drugs, the vast majority of young people do not use 
these substances, nor do they intend to do so in the future.  
Also evident is that there is no such thing as an ‘identikit’ user amongst that minority of young people 
who do actually use NPS. This is why the work that substance misuse and young people’s commissioners 
will undertake (as referenced above) can be so important for building an understanding of local profile of 
need. 
“Do we know why young people use NPS?”
As is the case with alcohol and a variety of illegal drugs, curiosity is one of the reasons that young people 
might be tempted to use NPS. Of course, for some people, we can’t ignore that the enjoyment of the 
effects of NPS products will be a key motivation for use. They can offer escapism, relaxation, shared social 
experiences and adventure. The extent to which a young person feels resilient or marginalised will impact 
greatly on their perception of how attractive these effects are. Added to this, for some young people, there 
will be the misguided perception that these drugs are legal will add to their attraction. 
Perhaps exacerbated by local and national news coverage around these substances, 
young people are now much more aware of this market than they were before the rise 
of mephedrone. Practitioners are getting more questions about the nature and effects of 
certain NPS from young people. 
Different people will of course be drawn to different NPS products due to a preference for 
different desired effects. If you think about the five categories of NPS talked about earlier we 
1 Health and Social Care Information Centre; Smoking, drinking and drug use 
among young people in England
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could assume that those who may have been tempted by an illegal drug such as ecstasy may take, what 
they think to be the “legal” and safe equivalent. 
Compared to cannabis, many synthetic cannabinoids tend to produce their effect at lower dosages and 
may be seen as more cost-effective than cannabis. This is another factor that may affect choice. However, 
this doesn’t avoid the risks, such as the risk of one-off, acute toxic reactions or the development of 
dependence with repeated use; and an increasing number of service users have reported such issues in 
relation to these ‘smoking blends’. 
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   Interventions &  
approaches
When discussing NPS or other drugs with young people, it is best to avoid talking about them in isolation. 
Rather they should be discussed as part of a wider package of skills development and support that can 
equip young people to a safe transition into adulthood.
Advice and information
The misperception of “legal” equating to “safe” seems thankfully to be shifting but we should not take 
this for granted. It is essential that young people get up-to-date and accurate information about these 
substances but broader support is needed too. Friendly and confidential drugs advice is available on 
FRANK. However it is important to understand that with NPS, up-to-date and accurate information may 
not always be available because of their novel and evolving nature. The One New Drug a Week2 report 
notes that as NPS become more established, other associated harm may take time to emerge, particularly 
in relation to the newer substances where it is too early to predict the negative effects of their use. It is 
therefore important to ensure young people are aware of the risks of not knowing exactly what short- and 
long-term impacts their NPS use may have.
Prevention 
The ability to make informed choices is important but this must be reinforced by general work on resilience, 
assertiveness and confident decision-making. The tools and approaches employed when working with 
young people about the use of any drug are entirely relevant to so called “legal highs”. 
PHE has now launched its Rise Above campaign for 11 to 16-year olds to prepare them for this transition 
into adulthood. Through content and activities, it will help young people to build resilience, prevent them 
from engaging in risky health behaviours and delay the uptake of more adult behaviours i.e. drugs or 
alcohol.
Prevention approaches that:
 •  target generic risk factors (eg, truanting, unstable home environments, offending)
 •   build resilience and social capital (eg, good social networks, stable homes)
 have been shown to increase the likelihood of preventing people from developing harmful drug using 
behaviour. These approaches build resilience by:
2 Faculty of Addictions Psychiatry, Royal College of Psychiatrists. One new 
drug a week: Why new psychoactive substances and club drugs need a 
different response from UK treatment providers. Faculty report, 2014.
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 •  supporting people
 •  giving them opportunities for alternative healthier life-choices
 •  improving their skills, decision making and social capital.
Resilience building, more so than specific drugs prevention activity, has the best evidence for helping 
people to avoid drugs and drug problems. However, programmes focused on building skills and attitudes to 
health are also worth considering. 
NPS interventions and treatment
Treatment data on NPS is currently limited, but what is available shows that demand for NPS treatment is 
low compared to many other traditional illicit drugs, though it is increasing over recent years. It also shows 
that NPS and club drug users respond well to treatment and that successful completion is comparatively 
high.
Drug services need to ensure staff are competent to treat and provide harm reduction for specific health 
problems. They also need to make themselves accessible to new groups of NPS users, which may include 
developing new pathways into treatment (e.g. by delivering brief intervention and referral services in sexual 
health clinics or young people’s centres or offering late night drop ins).
Drug treatment services can largely adapt current approaches to working with users of traditional drugs 
rather than inventing new ones. The key is to focus more on individuals and their symptoms than the 
specific drugs they are taking. This means key-workers can work in a personalised way with the issues 
people are presenting to them. Drug workers need to know the main NPS groups, their physical and 
psychological effects, how to reduce harm, and what interventions are most effective at treating people 
using NPS.
In most cases, treatment involves motivational interventions to help people consider the health risks 
and other costs of using NPS, to help them reduce harm, make behavioural changes, moderate or stop 
their drug use, and to prevent relapse. Treatment may also need to include health and wellbeing support, 
psychosocial therapy and complementary therapies such as acupuncture. 
Project NEPTUNE is an independent clinical expert group that has developed guidelines on treating acute 
NPS problems. When they are published in 2015, the guidelines will give detailed information on NPS and 
club drugs, their effects, treatment approaches, aftercare and harm reduction. It will be the key guidance for 
A&E, drug treatment and other services that deal with people who have NPS problems.
Neptune 2 is a 2½-year funded programme which will develop training packages and modules 
aimed at a wide range of health professionals in a variety of settings (e.g. A&E, sexual 
health clinics, lung specialists). Packages will incorporate guidance on screening, clinical 
management and brief interventions for NPS. The first products will be published in spring/
summer 2015, and the entire programme of work will be independently evaluated.
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   Further information  
and resources
Here is some further useful information about NPS and links to some resources that you may find 
helpful.
More details on NPS and the effects:
 •   The Drugs Wheel content provides information on the  categorisation of substances and also their 
effects: 
  •   Substances: http://www.thedrugswheel.com/
  •   Effects: http://www.thedrugswheel.com/downloads/TheDrugsWheelEffects_1_6.pdf
 •   NPS factsheets from DrugWatch UK, cover different substances in detail, including composition, 
dosage and effects 
 •   The national drugs information and advice service FRANK includes advice on local treatment 
services 
 •   The Angelus Foundation provides information and advice on “legal highs” as it aims  to educate, 
encourage and assist individuals to be more knowledgeable about the risks to their health and 
wellbeing of using “legal highs” and other NPS. It has a variety of videos which can be shown to 
clients and has a section for parents / carers of the substance misuser. 
NPS usage
 •   DrugScope’s ‘Business as usual’ report provides a useful introduction and background to NPS and 
‘club drug’ use in the UK.
 •   ‘One new drug a week: why new psychoactive substances and club drugs need a 
different response from UK treatment providers’ published by the Royal College of 
Psychiatrists’ Faculty of Addictions is a useful introduction to NPS use, harm and 
interventions.
 •   The Global Drugs Survey: is an international drug use survey which includes health 
advice
 •   The Home Office evidence review on NPS in England ‘NPS in England: a review of 
the evidence’
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Programmes and tools
 •   PHE’s Rise Above campaign for 11 to 16-year olds to prepare them for this transition into adulthood. 
Through content and activities, it helps young people to build resilience, prevent them from engaging 
in risky health behaviours and delay the uptake of more adult behaviours i.e. drugs and alcohol.
 •   Mentor UK ADEPIS provides the most current and up to date information and resources about 
alcohol and drugs for working with young people in schools and non-formal settings. The RisKit 
programme in particular has been found to significantly reduce alcohol use and reductions in illicit 
drug (mostly cannabis) use were also seen. 
 •   The Early Intervention Foundation guidebook is an online resource for commissioning and delivering 
effective early intervention.
 •   The Good Behaviour Game is an evidence-based approach to classroom management, shown to 
have dramatic benefits on children’s behaviour in school, and long-term positive effects on their life 
chances.
 •   Re-Solv provide support and advice for those affected by volatile substance abuse. There are a 
range of resources on the Re-Solv website including leaflets, school material and activity packs for 
practitioners. 
Quality standards
 •   ADEPIS quality standards for alcohol and drug education help schools and other drug education 
providers to assess their practice and deliver high-quality evidence-based education. 
 •   European drug prevention quality standards are produced by European Monitoring Centre for Drugs 
and Drug Addiction and Prevention Standards Partnership and describes basic and expert-level 
quality standards for drug prevention.
Additional resources
 •   The New psychoactive substances review: report of the expert panel (2014) looks into the 
effectiveness and issues of the UK’s current legislative and operational response to NPS and the 
ongoing challenges
 •   The Home Office Response to expert panel report on the new psychoactive substances review 
(2014) responds to the recommendations and advice made by the expert panel reviewing the UK’s 
response to NPS
 •   Updates on UK drug policy and delivery can be found on the Home Office website. Latest reports 
and evidence on NPS from the Advisory Council for the Misuse of Drugs can also be found on their 
website.
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  Case studies
There are already some resources and practical tools out there to help you in your interactions with 
young people when discussing the risks and consequences of drugs. 
The case studies below describe some of these and how they are used and relied on in group or one-
to-one sessions with young people. Not every tool will work for every group or young person and 
particularly different age groups, so you will need to apply your expert knowledge of the situation/
age/person to decide which resource or tool is best to use.
Becka Jarvis is a Senior Youth Worker and Youth Team Manager of 
Youthfirst, the youth wing of CVS, Community First Havant and East 
Hampshire.
“As the focus of Youthfirst’s work is to provide quality local youth work, with a special emphasis on working 
with the most vulnerable young people in our communities, my role is very varied. I develop and deliver a 
wide range of different kinds of youth work, from a Not in Education or Training (NEET) project run out of the 
local jobcentre, through Anger Management and Anxiety Management provision for young people, to Youth 
Clubs for local teenagers.
As such, a lot of my work touches on substance education and substance use issues. We have an 
emphasis on positive activities and preventative help and support, often around risky sexual behaviours and 
experimentation with drugs and alcohol. We also do work with NEETs and pre-NEETs, often on a one-to-
one basis, many of whom have issues with substance misuse alongside other difficulties. 
The specific risks are many: current legality giving an appearance of safety;  local ‘Head Shops’ making it 
seem as though these are cheap, harmless and consequence free; lack of clear knowledge about contents 
and provenance of substances; unknown short-term effects of largely untested chemicals; unknown long 
term effects of cheap ‘new’ highs; developing a tendency to look for a ‘legal’ way to escape life’s difficulties 
rather than engaging with them and learning skills to cope; withdrawal from ordinary life such as school/
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college; damaging significant relationships  due to behaviour whilst under the influence or 
coming down, and so on. 
My favourite tools, and the ones that work best, are those that in some way capture curiosity 
and spur young people to investigate things for themselves – based on the premise that what 
we discover for ourselves, through interest, teach us much more profoundly and stays with us 
longer than what other people teach ‘at’ us. Some of my favourites include the games below, 
which I give in skeleton form so they are flexible enough to be fleshed out in many ways and 
can be adapted to suit individuals, groups or locations:
 •   Pass The Parcel: a recurrent favourite game that can be used to get discussion on a topic started 
as it can help highlight the highs and lows of drugs. It can be adapted in many ways and is useful 
for conversations on drugs education. In each layer of the parcel  for each gift usually sweets or 
other treats, include written examples or pictures of :‘things you might get at a house party at a 
mate’s house’, ‘things you might get at a festival’, or even ‘things you might get at the local Head 
Shop’. “Things” here include both physical things – drinks, pills, powders, bongs etc or experiences 
such as ‘a trip in an ambulance and a yelling at by parents’ ‘a big debt to pay off’, ‘puking in front of 
everyone’ or ‘a great kiss’. Remember to ensure you are including balanced statements so that the 
group are being made aware of all the risks and consequences in order to support them in making 
informed choices.
 •   Angels or Demons on your shoulder: This is a scenario game where you need a group of young 
people to sit in a circle; this enables everyone to take three different roles during the game, without 
any gaps. The first decider is dealt a ‘situation’ card – can be on any topic such as ‘your best friend 
offers you a pill at a party’. The person to the left has to play the angel who explains why they 
should think twice and refuse it because of the risks involved. The person playing the demon on the 
right hand side will then try and persuade them into it.The decider then has to decide what they’d 
do and explain their reasons to the group. What you’re after is young people learning to weigh up 
options and make informed decisions, which they can explain. You will need to ensure that the 
discussion remains balanced so that the “decider” is able to make and informed decisions on the 
behaviours they are considering. Play then moves to the right, with the aim that everyone gets to 
experience giving both good and bad advice, and having to consider opinions and make a decision. 
You just have to make sure you have as many scenario cards as you have players, and you don’t put 
more than 10 in a circle or you’ll be there for hours. You get lots and lots of great discussions this 
way, and a lot of reflection on what advice young people give to each other in drug-use situations.
 •   Hierarchies:  This is where a series of actions/motives/things are written on individual cards and 
a young person has to decide to place these cards on a spectrum. This is often done with a set 
of possible interactions between two people in some kind of dating/relationship scenario, where 
things such as ‘holding someone’s hand’, ‘having a baby with someone’, or ‘meeting your parents’ 
are ranked in order of how important someone thinks they are, or how fast they think these should 
happen in a relationship, or which order (if at all) these things should happen in a relationship. 
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This can easily be converted to various kinds of drugs education, for example getting a young person to 
rank the reasons why young people take drugs or what risks and consequences are likely to be the most 
effective at persuading young people not to take drugs. A lot of discussion happens as a young person 
moves the cards, maybe discards some, or writes new ones to add to the mix, before coming to a final list. 
•   Drugs box or facsimile games: I also use the more sophisticated drugs box, where you have 25 or 
so small glass bottles with fake drugs in them and labelled only with numbers. You could also mock 
something similar up with small bags of flour, crushed sugar, bicarbonate of soda etc. You just have to 
make sure, if you have a bag that can be opened, that whatever is in it is utterly harmless.
You can pick several with similar looking substances and ask young people a series 
of questions about them, such as ‘which of these could you use as a battlefield 
anaesthetic?’ ‘Which would kill you if I let you eat this much?’, ‘Which would get you 
two years in prison and which 10?’ allowing them to think about the evaluation of 
unknown substances and their potential risks. These kinds of resources again are very 
flexible and you can easily adapt them to individuals, groups or locations.
Much of my approach to supporting NPS user uses skills learned from short solution-focused intervention 
and motivational interviewing training, along with those from Cognitive Behaviour Therapy (CBT). These 
enable me to keep the focus on the real issues, help the young person understand their motivations and 
discuss how to fulfil their needs in a more positive manner. With the user, I also do a fact finding session on 
their NPS of choice, and why it is a poor option for self-medication. We are working on encouraging more 
realistic thought, and using true-life stories of those in the public eye whose drug use has been significant.
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Georgia Ramsay-Smith is New Psychoactive Substance &  
Club Drug Outreach Worker in Brighton and Hove.
“My role was designed in response to the emerging trends and increasing levels of NPS and the associated 
risks in Brighton and Hove, with the key target of reducing A&E related admissions and re-admissions, 
engaging individuals on an assertive outreach basis, and sharing information with other services throughout 
the city. 
I was employed by CRI, Crime Reduction Initiatives, but also had an ‘honorary contract’ with Brighton & 
Sussex University Hospitals NHS Trust so that I could carry out follow up phone calls / letters to individuals 
that had presented at the Emergency Department and mentioned the use of an NPS or Club Drug.  
I received various responses from the follow up calls such as ‘Ending up in A&E has been a wakeup call for 
me, I’m not ever using drugs again’, ‘I don’t do drugs, my drink was spiked’, to ‘yes, I need some help, my 
drug use is out of control’. Some of the individuals that I supported into treatment through this pathway had 
over 100 previous A&E admissions yet had never been in substance misuse treatment before. 
As the role was completely new, I’ve had to decide what/who to prioritise; I targeted University Students, 
Sixth Form Colleges, hostels, homeless drop in centres, Young People’s Centres, Mental Health Services, 
and of course A&E. I set up satellite ‘drop-ins’ within the Universities, Colleges and hostels but found these 
weren’t well attended, however, if I attended an event such as Fresher’s Fair / Health & Wellbeing Days, 
plenty of people were keen to engage in meaningful conversations about NPS, such as their experiences or 
how to stay safe when using them. 
Initially the focus of the role was to advertise the service, to let the city know that there was a 
specialised service for people that want information, support, or advice around NPS. This was 
done by creating posters / leaflets which were distributed throughout the city (focussing on 
Primary Care & Educational settings), by promotion through a Twitter account (@ClubDrugs_
CRI) and Think Drink Drugs website (www.thinkdrinkdrugs.co.uk), sending out referral forms 
to services and promotion on various other websites such as CRI, Student Union Websites and Facebook 
profiles such as The Young People’s Centre. 
There is no ‘typical NPS user’, they span across all ages, some are new to drug use, many had moved 
away from illegal drugs and onto legal ones to avoid criminal activity or presuming that as they were legal 
and sold on the high street, that they had been tested and were deemed safe. The main reasons people 
were accessing treatment was due to becoming dependant on the substance and/or experiencing physical/
psychological problems. 
In my experience, the main reason for NPS use in the younger population is due to boredom or friendship 
groups and the difficulty of leaving a friendship group. In this case, suggesting other activities for young 
people and helping them build resilience is absolutely important. The main reason for adult’s use of NPS 
would be due to stress at work, using it to relax, or moving away from illegal drugs. In this situation, the 
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focus would be around how to handle stress, looking at coping mechanisms, goal setting, referral to 
counselling services and advising about the dangers and risks associated with NPS. 
The main risks associated with NPS is how new they are and thus not knowing the long term effects on 
physical or psychological health. Other risks are that you can never be sure what is in the packet, “legal 
highs” can easily be mislabelled, mispackaged, and mis-sold as a different substance which the end user is 
unanware of. Some new users don’t know what or where “legal highs” come from. The main risk is the risks 
people are taking, knowing next to nothing about a suspicious white powder but happy to sniff it. 
It is also challenging having to constantly keep up to date with new drugs, changes in policies etc, part of 
the job is to research and this is as important as engaging clients. The best source of information is the user 
themselves and it empowers them to provide you with their knowledge and experiences. Stay in the know, 
listen to the news, follow similar services on Twitter, Facebook, etc. At the same time, try not to be flustered 
when someone mentions a drug which you have never heard of – treat the service user as the expert and 
learn from them. 
I’d also recommend that practitioners don’t assume the user will come to you, take services into the 
community on an outreach basis. There is a lot of stigma around drug treatment and users of NPS won’t 
necessarily know there is a service out there for them, so promote it far and wide. 
There are a number of tools that I use regularly - with younger people or in drop-in centres, interactive tools 
work well. This may be a True/False quiz, a questionnaire, guessing the name of a drug from a picture or 
using the Outcomes Star (TM) to identify support needs and goals, agree priorities and measure progress 
against goals. Some of these are featured in this resource pack in the appendix and all aim to use materials 
that stimulate conversations.
Below, a young person that I’ve worked with talks about their experiences with NPS:
“I am bi-polar and after yet another spell in Millview Hospital, my mental health worker took me to 11 St 
George’s Place to see their specialist “legal highs” worker. I have self-medicated for years with all sorts of 
drugs but things went really wrong for me when I discovered “Poke”. I had started buying it nearly a year 
ago and at first it was just an occasional treat but as time went on I was using it every day for days on end. I 
was smoking it in a pipe like crack. 
Whilst I was on poke, I felt great. It made me really creative and I would sit for hours and write things 
down, or clean my flat from top to bottom. When I tried to stop, I had the worst come-downs I have ever 
experienced. I was unable to leave my flat for days as the anxiety would be unbearable. The head 
shop was giving me credit so I was also getting into debt with them. 
Georgia gave me lots of information about poke and I got very frightened about what I was 
doing to myself. I ended up in A&E loads of times because I thought I was having a heart 
attack or I would get really psychotic and put myself at risk. Georgia worked alongside my 
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Community Psychiatric Nurse (CPN) and also my worker from the Recovery Support Service. We have 
weekly meetings and I feel really supported by all my workers.
Georgia suggested rehab but I thought they wouldn’t take me because I was only using poke. I was 
assessed for funding to go to a dual diagnosis unit and was really lucky as I have been told I have got 
funding. I am so pleased. We are going to visit some rehabs to see which one I like. I still use poke 
sometimes at the moment but it has really reduced. I can finally see a light at the end of the tunnel because 
I really thought I was going to end up dead.”
Pete Xeros, Jade Gora & Justin Laidler are part of the youth  
offending team for North Tyneside
We work with all young people aged 10-18 with a focus on those who have offended, and who have come 
into contact with the youth justice system. We hold a generic case load, meaning we work with young 
people who have committed their first offence right up to those leaving custody.
Our key responsibilities are: 
 •   to reduce reoffending and the number of young people entering the formal youth justice system (first 
time entrants) 
 •   to minimise the number of young people going into custody. 
All of the work we do is directed by legislation and the Youth Justice Board’s National Standards.
The young people we work with come from a wide range of backgrounds. While the problems they 
experience are very specific to their own circumstances, common themes include: poor school attendance, 
substance and alcohol misuse, emotional difficulties, family problems, negative peers; speech language and 
communication difficulties; whilst some are just struggling with adolescence and growing up. As varied as 
their needs can be, sometimes it’s just about having a solid relationship with an adult and making sure we 
are reviewing our involvement throughout.
As part of our role we educate young people on how NPS work and the health and social implications of 
use; however, in order to be successful it is crucial that the young person is open and willing to quit. Simply 
trying to get someone to stop is not going to work; it is about replacing their use with something of value in 
their lives, if not their family then through training and employment, something which outweighs their use of 
NPS. We work very closely with all other services to achieve these positive results. 
New Psychoactive Substances | 19
   Appendix 1:  
Additional resources
•	 Guess the Drug Quiz, recommended by Georgia Ramsay-Smith,  
New Psychoactive Substance & Club Drug Outreach Worker in Brighton and Hove.
•	 “Legal highs” myth-busting Quiz, recommended by Georgia Ramsay-Smith,  
New Psychoactive Substance & Club Drug Outreach Worker in Brighton and Hove.
•	  “Legal highs” analysis map, recommended by Georgia Ramsay-Smith,  
New Psychoactive Substance & Club Drug Outreach Worker in Brighton and Hove.
•	  “Legal highs” impact evaluation tool, recommended by Georgia Ramsay-Smith,  
New Psychoactive Substance & Club Drug Outreach Worker in Brighton and Hove
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   Guess the drug,  
its legal status,  
and its effect! 
This activity is a good conversation starter as it helps to test people’s 
knowledge about different drugs. It allows you to highlight the risks people 
take when they use unknown substances. We’ve only added the legal 
consequences below, but you can check www.talktofrank.com to add in 
health harms as well. 
The aim of the game is to highlight that no-one can be sure what a drug is just 
by looking at it. Throughout the game it should be made clear that for all drugs, 
and so called “legal highs”,  ‘you never know what it is or what you’re getting’. 
So called “legal highs” are often cut with other substances, therefore you can 
never be sure if the contents of the pack are the same as on the description on 
the packet, or whether it has – in fact – been cut with illicit substances. Every 
new packet should be treated as a brand new / unknown substance.
Additional  
Resources
Notes
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Guess the drug, its legal status, and legal category!  
Question Sheet
Additional  
Resources
What is it?
Legal status? 
Category?
What is it?
Legal status? 
Category?
What is it?
Legal status? 
Category?
What is it?
Legal status? 
Category?
What is it?
Legal status? 
Category?
What is it?
Legal status? 
Category?
1
3
5
2
4
6
Notes
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Guess the drug, its legal status, and its effect! 
Answer Sheet
All answers have been taken from the Talk to FRANK website
1. Heroin
What heroin is:  Heroin is a depressant. Heroin is a drug made from morphine, 
which is extracted from the opium poppy. Opium has been around for many 
hundreds of years and was originally used to treat pain, sleeplessness and 
diarrhoea. When morphine is made into heroin to be used as a medicine, it’s 
called diamorphine, and is stronger than morphine or opium. Like many drugs 
made from opium (called opiates), heroin is a very strong painkiller. ‘Street’ 
heroin sold as ‘brown’ is sometimes now used by clubbers as a chill out drug 
after a big night out.
It is still just the same street heroin but some people mistakenly think it’s not as 
addictive.
Legal status: •   Heroin is a class A drug, so it’s illegal to have for yourself, 
give away or sell.
   •   Possession is illegal and can get you up to seven years in jail 
and/or an unlimited fine.
   •   Supplying someone else, even your friends, can get you up to 
life imprisonment and/or  
an unlimited fine.
Category: A
2. Ketamine 
What ketamine is: It’s a powerful general anaesthetic which stops you feeling 
pain and it’s used for operations on humans and animals. The effects don’t last 
long, but until they wear off, ketamine can cause a loss of feeling in the body 
and paralysis of the muscles. It can also lead to you experiencing a distortion of 
reality.
Legal status: •   Ketamine is a Class B drug which means that it’s illegal to 
have for yourself, give away or sell.
   •   Possession can get you up to five years in prison and/or an 
unlimited fine.
   •   Supplying someone else, even your friends, can get you 14 
years in jail and/or an unlimited fine.
Category: B
Additional  
Resources
Notes
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3. Mephedrone which is a cathinone 
What cathinones are: The chemical ‘cathinone’ is a naturally occurring 
stimulant drug found in the plant, Khat.
Cathinones are the family of related chemicals, including cathinone and many 
synthetically produced chemicals, like mephedrone, methylone (M1) and MDPV. 
Cathinones are ‘cousins’ of the amphetamine family of drugs, which includes 
amphetamine itself (speed) and MDMA (ecstasy), and which have similar effects. 
Cathinones used to be sold online and in headshops as so called “legal highs”. 
Legal status: •   Cathinones are classified as Class B drugs which means that 
it’s illegal to have for yourself, give away or sell.
   •   Possession can get you up to five years in prison and/or an 
unlimited fine.
   •   Supplying someone else, even your friends, can get you 14 
years in jail and/or an unlimited fine.
Category: B
4. GHB / GBL
What GHB and GBL are: GHB / GBL are depressants. 
GHB (gammahydroxybutrate) and GBL (gammabutyrolactone) are closely 
related, dangerous drugs with similar sedative and anaesthetic effects. 
 GBL is converted to GHB shortly after entering the body. Both produce a 
feeling of euphoria and can reduce inhibitions and cause sleepiness. 
But both can kill and are particularly dangerous when used with alcohol and 
other depressant or sedative substances.
Legal status:  •   GHB and GBL are both Class C drugs - but GBL is available 
for legitimate use in industry, but if someone supplies or 
possesses them knowing or believing that they will be 
swallowed and ingested, they are committing an offence.
   •   Possession can get you up to two years in prison and/or an 
unlimited fine.
   •   Supplying someone else, even your friends, can get you 14 
years in jail and/or an unlimited fine
Category: C
Additional  
Resources
Notes
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5. Spice, which is a brand of synthetic cannabinoid
What synthetic cannabinoids are: Synthetic cannabinoids are chemicals 
that are made to act like the active part of cannabis, a substance called 
tetrahydrocannabinol (THC). As synthetic cannabinoids act like cannabis the 
effects - good and bad - are likely to be very similar to cannabis. Some users 
will feel happy and relaxed, may get the giggles, feel hunger pangs and become 
very talkative. Others may feel ill or paranoid.
Synthetic cannabinoids are usually sold in ‘herbal’ smoking 
mixtures. Sometimes these smoking mixtures have been 
found not to contain any synthetic cannibinoids at all!
Legal status: •   A large number of synthetic cannabinoids and any mixtures 
that contain these synthetic cannabinoids, including Black 
Mamba and Annihilation, are Class B drugs and are illegal 
to have, give away or sell. Some products have been found 
to contain synthetic cannabinoids that are currently legal 
to possess, but as you can’t be sure what’s in any smoking 
mixture, when you purchase one you always run the risk that 
you may be in possession of a Class B drug.
   •   Possession of products containing controlled synthetic 
cannabinoids can get you up to five years in jail and/or an 
unlimited fine.
   •   Supplying someone else, including your friends, can get you 
fourteen years in jail and/or an unlimited fine.
Category: Maybe legal, but could contain numerous illegal substances of 
various classifications. There’s no way for you to know. 
6. PMA or PMMA
What PMA is: PMA is a stimulant. PMA and PMMA are closely related drugs 
similar to MDMA (the chemical in ecstasy) and can  make you feel alert, alive 
and full of energy. Their similarity means that PMA and PMMA are sometimes 
sold as ecstasy. However, PMA and PMMA are more poisonous and can kill 
at lower doses than MDMA. Also like MDMA, it can cause a fatal rise in body 
temperature. The effects of PMA and PMMA also take longer than MDMA to 
begin to be felt – so some users have overdosed by mistakenly taking pill after 
pill thinking nothing is happening, which can also be fatal.
In recent years there have been a number of deaths and hospitalisations that 
have been linked to PMA and/or PMMA. It appears that those affected thought 
they were taking ecstasy pills containing MDMA and did not know that the pills 
Additional  
Resources
Notes
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contained PMA and/or PMMA. As with any drug you can never be sure what it is 
your buying and how it might affect you.
As PMA and PMMA are often sold as ecstasy pills rather than sold by their own 
name, a lot of the street names associated with them are actually street names 
for ecstasy pills. Sometimes PMA and/or PMMA containing pills even look like 
regular ecstasy pills.
 
Legal status:  •  It’s illegal to have for yourself, give away or sell.
   •   Possession can get you up to seven years in prison and/or an 
unlimited fine.
   •   Supplying someone else, even your friends, can get you a life 
sentence and/or an unlimited fine.
Category: A
Additional  
Resources
Notes
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   “Legal highs”  
myth-busting quiz
Myth-busting quizzes can be a great conversation starters and allow you to 
discuss risks, harms and consequences with young adults. 
Myth one: “Legal highs” aren’t as strong as  
illegal drugs
True or false? FALSE
In fact, some “legal highs” are potentially stronger than illegal drugs, while some 
are also mixed with illegal substances. Illegal drugs such as cocaine or MDMA 
are usually mixed with all sorts of rubbish like caffeine pills and baking soda as 
they travel from being harvested to being sold on the streets, but this doesn’t 
tend to happen with “legal highs”, leaving them to be purer and more potent. 
Even plants and herbs sold as “legal highs” can be extremely strong, for 
example, Salvia is so strong users have reported they actually believe they are a 
sofa or have been trapped in Facebook after taking it. 
Myth two: “Legal highs” are safe
True or false? FALSE
This is one of the biggest misconceptions about so-called “legal highs”. Just 
because they are for sale, doesn’t mean they are safe or in fact legal. New 
batches of “legal highs” are mixed up quickly to dodge new laws and haven’t 
been tested for human consumption. So you’re playing guinea pig. Most “legal 
highs” are similar to illegal drugs and so are expected to cause a similar wide 
range of harms, with hospital admissions and deaths linked to NPS increasingly 
being reported.
Myth three: “Legal highs” are legal. Duh!
True and false? IT DEPENDS! 
When you buy a “legal high” there is only one way to know for sure what you 
have brought – to test it in the lab. For all you know you’ve got an illegal 
Additional  
Resources
Notes
New Psychoactive Substances | 27
substance there. 19.2% of NPS samples collected by the Forensic Early 
Warning System in 2013-14 contained controlled drugs. 
So you might think you’re on the right side of the law but, as well as risking your 
health, you could still be taking something illegal because you have no idea 
what it is you are taking. 
Myth four: “Legal highs” can kill you 
True or false? TRUE 
Whether it’s through a direct effect, such as raising the body’s temperature 
or stopping breathing, or by making you more likely to have an accident any 
drug that effects how the body and mind work can kill. “Legal highs” can be 
especially problematic because some are effective at very low doses, which 
make it very easy to overdose. There is no way of telling how your body will 
respond to a substance. Plus mixing “legal highs” with medication, illegal drugs 
or alcohol can increase the risk.
Myth five: You can safely mix “legal highs” with 
alcohol
True or false? FALSE
Alcohol is a depressant, this  means it slows down the central nervous system 
which controls the heart and breathing rate. So combining alcohol with any drug 
including “legal highs” isn’t a good idea and can seriously upset your body. For 
example, mixing alcohol with another depressant drug could stop you breathing 
altogether. 
Myth six: Legal drugs come from a less dodgy source 
True or false? TRUE
Most “legal highs” are made in China and sent legally into this country. 
However, this doesn’t make the “legal high” industry candidates for outstanding 
citizen awards. They’re still rather shady business people with an interest in 
profit, not well-being. After all, they’re determinedly tweaking chemical formulas 
to dodge laws and mass-producing substances for human consumption without 
conducting any medical tests. So it’s naive to assume the “legal high” industry 
is a squeaky clean one.
Myth seven: “Legal highs” are cheaper than  
illegal drugs
True or false? MOSTLY TRUE
The pricing of drugs works just like any other business. It’s all to do with 
supply and demand. Supplying illegal drugs can be tricky and involves 
risky manoeuvres, dodging police raids and getting people to stuff things in 
themselves. All this pushes the price up. 
Notes
Additional  
Resources
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“Legal highs” avoid this, meaning that the process is simpler, supply is easier, 
there is no need to hide how “legal highs” are sold, all of which tends to reduce 
the cost of “legal highs”.
Myth eight: “Legal highs” are purer
True or false? PROBABLY
It’s supply and demand again. Illegal drugs are scarcer, in demand, and 
therefore likely to be mixed with all sorts of rubbish to stretch out the stock. 
So that rather expensive line of cocaine may contain more caffeine than 
cocaine. There’s less of a need to cut “legal highs” with so much other dubious 
substances.  But don’t assume this makes them safer. It makes them stronger 
and therefore easier to overdose on. Also, 19.2% of NPS samples collected 
by the Forensic Early Warning System in 2013-14 contained illegal controlled 
drugs. 
Myth nine: It’s easier to get the dosage right with 
“legal highs”
True or false? FALSE
They’re not aspirins. They don’t come with a recommended dosage printed 
on the label. Plus, they’re largely unregulated and untested. What worked for 
Graham-from-the-pub might not work for you. There is no way of telling how 
a “legal high” will affect you and how much to take. Plus, with the chemicals 
constantly changing to evade the law, even re-trying a “legal high” can be like 
trying it for the first time.
Myth ten: With “legal highs” you know what you’re 
getting
True or false? FALSE
Drug legislation is constantly changing. Therefore crafty “legal high” traders are 
constantly adapting their products to evade changes to the law. So your new 
legal purchase might look the same and be packaged the same as your last, but 
it could be completely different. “Legal highs” are just as risky as illegal drugs. 
Also, 19.2% of NPS samples collected by the Forensic Early Warning System in 
2013-14 contained illegal controlled drugs.
Notes
Additional  
Resources
New Psychoactive Substances | 29
   “Legal highs”  
analysis map
The following ‘map’ helps to guide a conversation between worker and client 
to determine what substances are being used. Along with asking clients what a 
substance is called or what it looks like, the map also asks for other information 
such as the environment it is taken in. It helps to determine risk to user or others 
and can be a conversation starter about safety. Young people or those with a 
learning disability may find it easier to fill in the sections on the ‘map’ rather than 
have an open conversation. 
Additional  
Resources
Notes
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Name:      Date:
“Legal highs” analysis map
What are they?
Where do they come from?
Are they safe?
How fun are they?
What’s the base?
What’s the name of  
what I use?
How much 
do I spend?
What does it 
look like?
How much
do I use?
Where do I 
get it from?
In what 
environment?
What does the package look like?
Can I draw it?
White powder? Like cannabis? 
Other?
Per day
Per week
Nights
Days
Weekdays
Weekends
Where?
Who with?
Alone or with mates?
In what mood?
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   “Legal highs” impact 
evaluation sheet 
This tool has been designed to use one to one with clients. It could be used in 
isolation or alongside the previous map which identifies the substance used. 
This approach breaks down potentially problematic areas into small sections 
so that they can be discussed one at a time. For example, ‘me today’ could 
be filled with the individuals feelings / emotions that day, how they feel there 
and then. The ‘problem areas’ section allows them to identify clearly what 
needs most focus e.g. money, homelessness etc. The scaling questions about 
psychological and physical health are to be completed at the beginning of 
treatment and progressively throughout the individuals support, hopefully seeing 
an improvement in both. 
Notes
Additional  
Resources
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Name:      Date:
Physical Health/
Last A&E Attendance
Drugs/Alcohol
Social Networks/
Relationships Problem Areas
Psychological 
Health
Client’s rating of psychological health status (anxiety, depression, problem emotions and feelings)
Client’s rating of physical health status (extent of physical symptoms and bothered by illness)
0
0
1
1
2
2
3
3
4
4
5
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
Poor
Poor
Good
Good
 “Legal highs” impact 
evaluation sheet 
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